Recurrent Malignant Female Reproductive System Neoplasm
6 clinical trials · Condition
◉ Watch Recurrent Malignant Female Reproductive System Neoplasm
| Record | Firm | Date |
|---|---|---|
| Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies (NCT04395079) | Jonsson Comprehensive Cancer Center | 2020-08-07 |
| Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer (NCT04266886) | M.D. Anderson Cancer Center | 2018-09-11 |
| Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors (NCT03420963) | M.D. Anderson Cancer Center | 2018-08-31 |
Track Recurrent Malignant Female Reproductive System Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.